nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—SLCO1B1—Dextrothyroxine—hypothyroidism	0.186	0.248	CbGbCtD
Sirolimus—SLCO1B1—Liothyronine—hypothyroidism	0.141	0.188	CbGbCtD
Sirolimus—SLCO1B1—Levothyroxine—hypothyroidism	0.141	0.188	CbGbCtD
Sirolimus—SLCO1B1—Liotrix—hypothyroidism	0.137	0.183	CbGbCtD
Sirolimus—ABCB1—Liothyronine—hypothyroidism	0.0403	0.0539	CbGbCtD
Sirolimus—ABCB1—Levothyroxine—hypothyroidism	0.0403	0.0539	CbGbCtD
Sirolimus—ABCB1—Liotrix—hypothyroidism	0.0393	0.0526	CbGbCtD
Sirolimus—CYP3A4—Levothyroxine—hypothyroidism	0.0241	0.0323	CbGbCtD
Sirolimus—EIF4E—heart—hypothyroidism	0.00481	0.0515	CbGeAlD
Sirolimus—EIF4E—cardiovascular system—hypothyroidism	0.00454	0.0486	CbGeAlD
Sirolimus—Tetany—Liotrix—hypothyroidism	0.00452	0.034	CcSEcCtD
Sirolimus—Hyperphosphataemia—Liotrix—hypothyroidism	0.00431	0.0325	CcSEcCtD
Sirolimus—Renal tubular necrosis—Liotrix—hypothyroidism	0.00413	0.0311	CcSEcCtD
Sirolimus—EIF4E—gonad—hypothyroidism	0.00412	0.0441	CbGeAlD
Sirolimus—EIF4E—blood—hypothyroidism	0.00359	0.0385	CbGeAlD
Sirolimus—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00326	0.0246	CcSEcCtD
Sirolimus—EIF4E—testis—hypothyroidism	0.00297	0.0318	CbGeAlD
Sirolimus—FGF2—heart—hypothyroidism	0.00294	0.0314	CbGeAlD
Sirolimus—EIF4E—liver—hypothyroidism	0.00281	0.0301	CbGeAlD
Sirolimus—Acidosis—Liotrix—hypothyroidism	0.00266	0.02	CcSEcCtD
Sirolimus—FGF2—pituitary gland—hypothyroidism	0.00245	0.0263	CbGeAlD
Sirolimus—Fluid overload—Liotrix—hypothyroidism	0.00237	0.0178	CcSEcCtD
Sirolimus—FGF2—adrenal gland—hypothyroidism	0.00219	0.0235	CbGeAlD
Sirolimus—CYP3A4—urine—hypothyroidism	0.00214	0.0229	CbGeAlD
Sirolimus—FGF2—thyroid gland—hypothyroidism	0.00211	0.0226	CbGeAlD
Sirolimus—FGF2—female gonad—hypothyroidism	0.00204	0.0219	CbGeAlD
Sirolimus—MTOR—heart—hypothyroidism	0.00186	0.0199	CbGeAlD
Sirolimus—Abscess—Liotrix—hypothyroidism	0.00186	0.014	CcSEcCtD
Sirolimus—FGF2—testis—hypothyroidism	0.00181	0.0194	CbGeAlD
Sirolimus—MTOR—cardiovascular system—hypothyroidism	0.00176	0.0188	CbGeAlD
Sirolimus—FKBP1A—adrenal cortex—hypothyroidism	0.00173	0.0185	CbGeAlD
Sirolimus—FKBP1A—heart—hypothyroidism	0.00168	0.0179	CbGeAlD
Sirolimus—FGF2—cerebellum—hypothyroidism	0.00167	0.0179	CbGeAlD
Sirolimus—Cellulitis—Liotrix—hypothyroidism	0.00162	0.0122	CcSEcCtD
Sirolimus—Hypocalcaemia—Liotrix—hypothyroidism	0.00161	0.0121	CcSEcCtD
Sirolimus—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.0016	0.0121	CcSEcCtD
Sirolimus—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.0016	0.0121	CcSEcCtD
Sirolimus—Oliguria—Liotrix—hypothyroidism	0.0016	0.012	CcSEcCtD
Sirolimus—MTOR—gonad—hypothyroidism	0.0016	0.0171	CbGeAlD
Sirolimus—FKBP1A—cardiovascular system—hypothyroidism	0.00158	0.0169	CbGeAlD
Sirolimus—FGF2—Differentiation Pathway—TPO—hypothyroidism	0.00157	0.0608	CbGpPWpGaD
Sirolimus—MTOR—pituitary gland—hypothyroidism	0.00156	0.0167	CbGeAlD
Sirolimus—Creatinine increased—Liotrix—hypothyroidism	0.00155	0.0117	CcSEcCtD
Sirolimus—Increased appetite—Levothyroxine—hypothyroidism	0.00155	0.0117	CcSEcCtD
Sirolimus—Increased appetite—Dextrothyroxine—hypothyroidism	0.00155	0.0117	CcSEcCtD
Sirolimus—Hypertension—Liothyronine—hypothyroidism	0.00154	0.0116	CcSEcCtD
Sirolimus—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00149	0.0112	CcSEcCtD
Sirolimus—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00149	0.0112	CcSEcCtD
Sirolimus—SLC47A1—adrenal cortex—hypothyroidism	0.00149	0.0159	CbGeAlD
Sirolimus—SLC47A1—heart—hypothyroidism	0.00144	0.0154	CbGeAlD
Sirolimus—FKBP1A—gonad—hypothyroidism	0.00143	0.0154	CbGeAlD
Sirolimus—Affect lability—Levothyroxine—hypothyroidism	0.00143	0.0108	CcSEcCtD
Sirolimus—Affect lability—Dextrothyroxine—hypothyroidism	0.00143	0.0108	CcSEcCtD
Sirolimus—Tachycardia—Liothyronine—hypothyroidism	0.00142	0.0107	CcSEcCtD
Sirolimus—FKBP1A—pituitary gland—hypothyroidism	0.0014	0.015	CbGeAlD
Sirolimus—Fluid retention—Liotrix—hypothyroidism	0.0014	0.0105	CcSEcCtD
Sirolimus—Blood urea increased—Liotrix—hypothyroidism	0.00139	0.0105	CcSEcCtD
Sirolimus—MTOR—adrenal gland—hypothyroidism	0.00139	0.0149	CbGeAlD
Sirolimus—MTOR—blood—hypothyroidism	0.00139	0.0149	CbGeAlD
Sirolimus—SLC47A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00139	0.0536	CbGpPWpGaD
Sirolimus—Mood swings—Dextrothyroxine—hypothyroidism	0.00138	0.0104	CcSEcCtD
Sirolimus—Mood swings—Levothyroxine—hypothyroidism	0.00138	0.0104	CcSEcCtD
Sirolimus—Hypotension—Liothyronine—hypothyroidism	0.00136	0.0102	CcSEcCtD
Sirolimus—Dehydration—Levothyroxine—hypothyroidism	0.00135	0.0102	CcSEcCtD
Sirolimus—Dehydration—Dextrothyroxine—hypothyroidism	0.00135	0.0102	CcSEcCtD
Sirolimus—MTOR—thyroid gland—hypothyroidism	0.00134	0.0144	CbGeAlD
Sirolimus—FGF2—Endochondral Ossification—THRA—hypothyroidism	0.00133	0.0514	CbGpPWpGaD
Sirolimus—MTOR—female gonad—hypothyroidism	0.0013	0.0139	CbGeAlD
Sirolimus—Sepsis—Liotrix—hypothyroidism	0.00128	0.00963	CcSEcCtD
Sirolimus—Dysphagia—Dextrothyroxine—hypothyroidism	0.00126	0.00946	CcSEcCtD
Sirolimus—Dysphagia—Levothyroxine—hypothyroidism	0.00126	0.00946	CcSEcCtD
Sirolimus—FKBP1A—adrenal gland—hypothyroidism	0.00125	0.0134	CbGeAlD
Sirolimus—FKBP1A—blood—hypothyroidism	0.00125	0.0134	CbGeAlD
Sirolimus—SLC47A1—gonad—hypothyroidism	0.00123	0.0132	CbGeAlD
Sirolimus—CYP3A7—liver—hypothyroidism	0.00121	0.0129	CbGeAlD
Sirolimus—FKBP1A—thyroid gland—hypothyroidism	0.00121	0.0129	CbGeAlD
Sirolimus—SLC47A1—pituitary gland—hypothyroidism	0.0012	0.0129	CbGeAlD
Sirolimus—Cardiac failure congestive—Liotrix—hypothyroidism	0.00118	0.00888	CcSEcCtD
Sirolimus—FKBP1A—female gonad—hypothyroidism	0.00117	0.0125	CbGeAlD
Sirolimus—Body temperature increased—Liothyronine—hypothyroidism	0.00115	0.00866	CcSEcCtD
Sirolimus—MTOR—testis—hypothyroidism	0.00115	0.0123	CbGeAlD
Sirolimus—Increased appetite—Liotrix—hypothyroidism	0.00114	0.00857	CcSEcCtD
Sirolimus—Weight decreased—Dextrothyroxine—hypothyroidism	0.00114	0.00856	CcSEcCtD
Sirolimus—Weight decreased—Levothyroxine—hypothyroidism	0.00114	0.00856	CcSEcCtD
Sirolimus—Renal impairment—Liotrix—hypothyroidism	0.00112	0.00846	CcSEcCtD
Sirolimus—FGF2—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.0011	0.0426	CbGpPWpGaD
Sirolimus—Hypoglycaemia—Liotrix—hypothyroidism	0.0011	0.00825	CcSEcCtD
Sirolimus—MTOR—liver—hypothyroidism	0.00109	0.0116	CbGeAlD
Sirolimus—SLC47A1—adrenal gland—hypothyroidism	0.00107	0.0115	CbGeAlD
Sirolimus—SLC47A1—blood—hypothyroidism	0.00107	0.0115	CbGeAlD
Sirolimus—Sweating—Levothyroxine—hypothyroidism	0.00107	0.00809	CcSEcCtD
Sirolimus—Sweating—Dextrothyroxine—hypothyroidism	0.00107	0.00809	CcSEcCtD
Sirolimus—MTOR—cerebellum—hypothyroidism	0.00106	0.0114	CbGeAlD
Sirolimus—SLCO1B1—blood—hypothyroidism	0.00106	0.0114	CbGeAlD
Sirolimus—Affect lability—Liotrix—hypothyroidism	0.00105	0.00793	CcSEcCtD
Sirolimus—SLC47A1—thyroid gland—hypothyroidism	0.00104	0.0111	CbGeAlD
Sirolimus—FKBP1A—testis—hypothyroidism	0.00103	0.0111	CbGeAlD
Sirolimus—CYP3A7-CYP3A51P—liver—hypothyroidism	0.00103	0.011	CbGeAlD
Sirolimus—Mood swings—Liotrix—hypothyroidism	0.00101	0.00763	CcSEcCtD
Sirolimus—Blood creatinine increased—Liotrix—hypothyroidism	0.001	0.00755	CcSEcCtD
Sirolimus—SLC47A1—female gonad—hypothyroidism	0.001	0.0107	CbGeAlD
Sirolimus—Dehydration—Liotrix—hypothyroidism	0.000995	0.00749	CcSEcCtD
Sirolimus—FKBP1A—liver—hypothyroidism	0.000978	0.0105	CbGeAlD
Sirolimus—Hypokalaemia—Liotrix—hypothyroidism	0.000973	0.00733	CcSEcCtD
Sirolimus—MTOR—TSH signaling pathway—PAX8—hypothyroidism	0.000963	0.0372	CbGpPWpGaD
Sirolimus—FKBP1A—cerebellum—hypothyroidism	0.000955	0.0102	CbGeAlD
Sirolimus—Abdominal distension—Liotrix—hypothyroidism	0.000931	0.00701	CcSEcCtD
Sirolimus—Dysphagia—Liotrix—hypothyroidism	0.000924	0.00696	CcSEcCtD
Sirolimus—SLCO1B1—Transport of organic anions—AVP—hypothyroidism	0.00089	0.0344	CbGpPWpGaD
Sirolimus—Bronchitis—Liotrix—hypothyroidism	0.000889	0.0067	CcSEcCtD
Sirolimus—SLC47A1—testis—hypothyroidism	0.000889	0.00951	CbGeAlD
Sirolimus—Tension—Levothyroxine—hypothyroidism	0.000859	0.00647	CcSEcCtD
Sirolimus—Tension—Dextrothyroxine—hypothyroidism	0.000859	0.00647	CcSEcCtD
Sirolimus—Nervousness—Levothyroxine—hypothyroidism	0.000851	0.00641	CcSEcCtD
Sirolimus—Nervousness—Dextrothyroxine—hypothyroidism	0.000851	0.00641	CcSEcCtD
Sirolimus—SLC47A1—liver—hypothyroidism	0.00084	0.00899	CbGeAlD
Sirolimus—Weight decreased—Liotrix—hypothyroidism	0.000836	0.0063	CcSEcCtD
Sirolimus—SLCO1B1—liver—hypothyroidism	0.000829	0.00888	CbGeAlD
Sirolimus—SLC47A1—cerebellum—hypothyroidism	0.000821	0.00879	CbGeAlD
Sirolimus—Tremor—Dextrothyroxine—hypothyroidism	0.00082	0.00618	CcSEcCtD
Sirolimus—Tremor—Levothyroxine—hypothyroidism	0.00082	0.00618	CcSEcCtD
Sirolimus—Agitation—Levothyroxine—hypothyroidism	0.000805	0.00606	CcSEcCtD
Sirolimus—Agitation—Dextrothyroxine—hypothyroidism	0.000805	0.00606	CcSEcCtD
Sirolimus—Angioedema—Levothyroxine—hypothyroidism	0.0008	0.00603	CcSEcCtD
Sirolimus—Angioedema—Dextrothyroxine—hypothyroidism	0.0008	0.00603	CcSEcCtD
Sirolimus—Sweating—Liotrix—hypothyroidism	0.00079	0.00595	CcSEcCtD
Sirolimus—Palpitations—Levothyroxine—hypothyroidism	0.000774	0.00583	CcSEcCtD
Sirolimus—Palpitations—Dextrothyroxine—hypothyroidism	0.000774	0.00583	CcSEcCtD
Sirolimus—Arthralgia—Levothyroxine—hypothyroidism	0.000746	0.00561	CcSEcCtD
Sirolimus—Arthralgia—Dextrothyroxine—hypothyroidism	0.000746	0.00561	CcSEcCtD
Sirolimus—Anxiety—Levothyroxine—hypothyroidism	0.000743	0.0056	CcSEcCtD
Sirolimus—Anxiety—Dextrothyroxine—hypothyroidism	0.000743	0.0056	CcSEcCtD
Sirolimus—Hypoaesthesia—Liotrix—hypothyroidism	0.000736	0.00554	CcSEcCtD
Sirolimus—Confusional state—Dextrothyroxine—hypothyroidism	0.000721	0.00543	CcSEcCtD
Sirolimus—Confusional state—Levothyroxine—hypothyroidism	0.000721	0.00543	CcSEcCtD
Sirolimus—Shock—Dextrothyroxine—hypothyroidism	0.000703	0.0053	CcSEcCtD
Sirolimus—Shock—Levothyroxine—hypothyroidism	0.000703	0.0053	CcSEcCtD
Sirolimus—Tachycardia—Dextrothyroxine—hypothyroidism	0.000698	0.00525	CcSEcCtD
Sirolimus—Tachycardia—Levothyroxine—hypothyroidism	0.000698	0.00525	CcSEcCtD
Sirolimus—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000691	0.0052	CcSEcCtD
Sirolimus—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000691	0.0052	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000651	0.0049	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000651	0.0049	CcSEcCtD
Sirolimus—Insomnia—Dextrothyroxine—hypothyroidism	0.000646	0.00487	CcSEcCtD
Sirolimus—Insomnia—Levothyroxine—hypothyroidism	0.000646	0.00487	CcSEcCtD
Sirolimus—Dyspnoea—Levothyroxine—hypothyroidism	0.000637	0.0048	CcSEcCtD
Sirolimus—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000637	0.0048	CcSEcCtD
Sirolimus—Flatulence—Liotrix—hypothyroidism	0.000635	0.00478	CcSEcCtD
Sirolimus—Tension—Liotrix—hypothyroidism	0.000632	0.00476	CcSEcCtD
Sirolimus—SLC47A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00063	0.0243	CbGpPWpGaD
Sirolimus—Nervousness—Liotrix—hypothyroidism	0.000626	0.00471	CcSEcCtD
Sirolimus—Tremor—Liotrix—hypothyroidism	0.000603	0.00454	CcSEcCtD
Sirolimus—Agitation—Liotrix—hypothyroidism	0.000592	0.00446	CcSEcCtD
Sirolimus—Feeling abnormal—Levothyroxine—hypothyroidism	0.000589	0.00444	CcSEcCtD
Sirolimus—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000589	0.00444	CcSEcCtD
Sirolimus—Angioedema—Liotrix—hypothyroidism	0.000589	0.00443	CcSEcCtD
Sirolimus—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.000584	0.0044	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.000584	0.0044	CcSEcCtD
Sirolimus—Syncope—Liotrix—hypothyroidism	0.000578	0.00435	CcSEcCtD
Sirolimus—Palpitations—Liotrix—hypothyroidism	0.000569	0.00429	CcSEcCtD
Sirolimus—Loss of consciousness—Liotrix—hypothyroidism	0.000566	0.00426	CcSEcCtD
Sirolimus—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000565	0.00425	CcSEcCtD
Sirolimus—Body temperature increased—Levothyroxine—hypothyroidism	0.000565	0.00425	CcSEcCtD
Sirolimus—Abdominal pain—Levothyroxine—hypothyroidism	0.000565	0.00425	CcSEcCtD
Sirolimus—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000565	0.00425	CcSEcCtD
Sirolimus—Hypertension—Liotrix—hypothyroidism	0.000556	0.00419	CcSEcCtD
Sirolimus—Arthralgia—Liotrix—hypothyroidism	0.000548	0.00413	CcSEcCtD
Sirolimus—Chest pain—Liotrix—hypothyroidism	0.000548	0.00413	CcSEcCtD
Sirolimus—Anxiety—Liotrix—hypothyroidism	0.000546	0.00412	CcSEcCtD
Sirolimus—CYP3A5—blood—hypothyroidism	0.000544	0.00583	CbGeAlD
Sirolimus—Confusional state—Liotrix—hypothyroidism	0.00053	0.00399	CcSEcCtD
Sirolimus—Anaphylactic shock—Liotrix—hypothyroidism	0.000526	0.00396	CcSEcCtD
Sirolimus—Oedema—Liotrix—hypothyroidism	0.000526	0.00396	CcSEcCtD
Sirolimus—FGF2—Integrins in angiogenesis—PIK3C2A—hypothyroidism	0.000522	0.0202	CbGpPWpGaD
Sirolimus—Infection—Liotrix—hypothyroidism	0.000522	0.00393	CcSEcCtD
Sirolimus—SLC47A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000522	0.0202	CbGpPWpGaD
Sirolimus—Shock—Liotrix—hypothyroidism	0.000517	0.0039	CcSEcCtD
Sirolimus—Tachycardia—Liotrix—hypothyroidism	0.000513	0.00386	CcSEcCtD
Sirolimus—Asthenia—Levothyroxine—hypothyroidism	0.000513	0.00386	CcSEcCtD
Sirolimus—Asthenia—Dextrothyroxine—hypothyroidism	0.000513	0.00386	CcSEcCtD
Sirolimus—MTOR—VEGFR2 mediated vascular permeability—VAV3—hypothyroidism	0.000509	0.0197	CbGpPWpGaD
Sirolimus—Hyperhidrosis—Liotrix—hypothyroidism	0.000508	0.00383	CcSEcCtD
Sirolimus—CYP3A5—female gonad—hypothyroidism	0.000508	0.00543	CbGeAlD
Sirolimus—Pruritus—Levothyroxine—hypothyroidism	0.000506	0.00381	CcSEcCtD
Sirolimus—Pruritus—Dextrothyroxine—hypothyroidism	0.000506	0.00381	CcSEcCtD
Sirolimus—Anorexia—Liotrix—hypothyroidism	0.000501	0.00377	CcSEcCtD
Sirolimus—Hypotension—Liotrix—hypothyroidism	0.000491	0.0037	CcSEcCtD
Sirolimus—Diarrhoea—Levothyroxine—hypothyroidism	0.000489	0.00368	CcSEcCtD
Sirolimus—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000489	0.00368	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000479	0.00361	CcSEcCtD
Sirolimus—Insomnia—Liotrix—hypothyroidism	0.000475	0.00358	CcSEcCtD
Sirolimus—Paraesthesia—Liotrix—hypothyroidism	0.000472	0.00356	CcSEcCtD
Sirolimus—Dyspnoea—Liotrix—hypothyroidism	0.000469	0.00353	CcSEcCtD
Sirolimus—Decreased appetite—Liotrix—hypothyroidism	0.000457	0.00344	CcSEcCtD
Sirolimus—Vomiting—Levothyroxine—hypothyroidism	0.000454	0.00342	CcSEcCtD
Sirolimus—Vomiting—Dextrothyroxine—hypothyroidism	0.000454	0.00342	CcSEcCtD
Sirolimus—Rash—Levothyroxine—hypothyroidism	0.000451	0.00339	CcSEcCtD
Sirolimus—Rash—Dextrothyroxine—hypothyroidism	0.000451	0.00339	CcSEcCtD
Sirolimus—Dermatitis—Levothyroxine—hypothyroidism	0.00045	0.00339	CcSEcCtD
Sirolimus—Dermatitis—Dextrothyroxine—hypothyroidism	0.00045	0.00339	CcSEcCtD
Sirolimus—Constipation—Liotrix—hypothyroidism	0.00045	0.00339	CcSEcCtD
Sirolimus—Headache—Dextrothyroxine—hypothyroidism	0.000448	0.00337	CcSEcCtD
Sirolimus—Headache—Levothyroxine—hypothyroidism	0.000448	0.00337	CcSEcCtD
Sirolimus—EIF4E—Insulin Signaling—PIK3C2A—hypothyroidism	0.000446	0.0172	CbGpPWpGaD
Sirolimus—Feeling abnormal—Liotrix—hypothyroidism	0.000433	0.00326	CcSEcCtD
Sirolimus—Gastrointestinal pain—Liotrix—hypothyroidism	0.00043	0.00324	CcSEcCtD
Sirolimus—CYP3A5—liver—hypothyroidism	0.000426	0.00456	CbGeAlD
Sirolimus—Nausea—Dextrothyroxine—hypothyroidism	0.000425	0.0032	CcSEcCtD
Sirolimus—Nausea—Levothyroxine—hypothyroidism	0.000425	0.0032	CcSEcCtD
Sirolimus—MTOR—TSH signaling pathway—TSHB—hypothyroidism	0.000419	0.0162	CbGpPWpGaD
Sirolimus—MTOR—TSH signaling pathway—TSHR—hypothyroidism	0.000419	0.0162	CbGpPWpGaD
Sirolimus—Body temperature increased—Liotrix—hypothyroidism	0.000416	0.00313	CcSEcCtD
Sirolimus—Abdominal pain—Liotrix—hypothyroidism	0.000416	0.00313	CcSEcCtD
Sirolimus—CYP3A4—blood—hypothyroidism	0.000408	0.00437	CbGeAlD
Sirolimus—ABCB1—adrenal cortex—hypothyroidism	0.000401	0.00429	CbGeAlD
Sirolimus—ABCB1—heart—hypothyroidism	0.000387	0.00415	CbGeAlD
Sirolimus—Hypersensitivity—Liotrix—hypothyroidism	0.000387	0.00292	CcSEcCtD
Sirolimus—Asthenia—Liotrix—hypothyroidism	0.000377	0.00284	CcSEcCtD
Sirolimus—Pruritus—Liotrix—hypothyroidism	0.000372	0.0028	CcSEcCtD
Sirolimus—EIF4E—Gene Expression—ZNF764—hypothyroidism	0.00037	0.0143	CbGpPWpGaD
Sirolimus—ABCB1—cardiovascular system—hypothyroidism	0.000366	0.00391	CbGeAlD
Sirolimus—Diarrhoea—Liotrix—hypothyroidism	0.00036	0.00271	CcSEcCtD
Sirolimus—FGF2—Integrins in angiogenesis—VAV3—hypothyroidism	0.000358	0.0139	CbGpPWpGaD
Sirolimus—Dizziness—Liotrix—hypothyroidism	0.000348	0.00262	CcSEcCtD
Sirolimus—Vomiting—Liotrix—hypothyroidism	0.000334	0.00252	CcSEcCtD
Sirolimus—EIF4E—BDNF signaling pathway—VAV3—hypothyroidism	0.000333	0.0129	CbGpPWpGaD
Sirolimus—ABCB1—gonad—hypothyroidism	0.000332	0.00355	CbGeAlD
Sirolimus—Rash—Liotrix—hypothyroidism	0.000331	0.0025	CcSEcCtD
Sirolimus—Dermatitis—Liotrix—hypothyroidism	0.000331	0.00249	CcSEcCtD
Sirolimus—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.00033	0.0128	CbGpPWpGaD
Sirolimus—Headache—Liotrix—hypothyroidism	0.000329	0.00248	CcSEcCtD
Sirolimus—ABCB1—pituitary gland—hypothyroidism	0.000324	0.00347	CbGeAlD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00032	0.0124	CbGpPWpGaD
Sirolimus—CYP3A4—liver—hypothyroidism	0.000319	0.00342	CbGeAlD
Sirolimus—Nausea—Liotrix—hypothyroidism	0.000312	0.00235	CcSEcCtD
Sirolimus—EIF4E—IRS-related events triggered by IGF1R—IGF1—hypothyroidism	0.000301	0.0116	CbGpPWpGaD
Sirolimus—EIF4E—IGF1R signaling cascade—IGF1—hypothyroidism	0.000293	0.0113	CbGpPWpGaD
Sirolimus—ABCB1—adrenal gland—hypothyroidism	0.000289	0.0031	CbGeAlD
Sirolimus—ABCB1—blood—hypothyroidism	0.000289	0.0031	CbGeAlD
Sirolimus—ABCB1—thyroid gland—hypothyroidism	0.000279	0.00299	CbGeAlD
Sirolimus—FGF2—Differentiation Pathway—IGF1—hypothyroidism	0.000274	0.0106	CbGpPWpGaD
Sirolimus—FGF2—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000274	0.0106	CbGpPWpGaD
Sirolimus—ABCB1—female gonad—hypothyroidism	0.00027	0.00289	CbGeAlD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000265	0.0103	CbGpPWpGaD
Sirolimus—FGF2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000262	0.0101	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.000254	0.0098	CbGpPWpGaD
Sirolimus—SLC47A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000252	0.00973	CbGpPWpGaD
Sirolimus—FGF2—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000246	0.00951	CbGpPWpGaD
Sirolimus—ABCB1—testis—hypothyroidism	0.000239	0.00256	CbGeAlD
Sirolimus—EIF4E—Gene Expression—THRA—hypothyroidism	0.000239	0.00922	CbGpPWpGaD
Sirolimus—ABCB1—liver—hypothyroidism	0.000226	0.00242	CbGeAlD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000225	0.00871	CbGpPWpGaD
Sirolimus—ABCB1—cerebellum—hypothyroidism	0.000221	0.00236	CbGeAlD
Sirolimus—FGF2—Integrins in angiogenesis—IGF1—hypothyroidism	0.000221	0.00853	CbGpPWpGaD
Sirolimus—FGF2—Endochondral Ossification—IGF1—hypothyroidism	0.000218	0.00843	CbGpPWpGaD
Sirolimus—EIF4E—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.000211	0.00817	CbGpPWpGaD
Sirolimus—MTOR—Signaling by SCF-KIT—SH2B3—hypothyroidism	0.000203	0.00786	CbGpPWpGaD
Sirolimus—SLC47A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000198	0.00766	CbGpPWpGaD
Sirolimus—FGF2—Signaling by ERBB4—PRL—hypothyroidism	0.000192	0.0074	CbGpPWpGaD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000187	0.00722	CbGpPWpGaD
Sirolimus—MTOR—Insulin Signaling—PIK3C2A—hypothyroidism	0.000184	0.00711	CbGpPWpGaD
Sirolimus—MTOR—Cardiac Hypertrophic Response—IGF1—hypothyroidism	0.000183	0.00706	CbGpPWpGaD
Sirolimus—FGF2—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.000175	0.00678	CbGpPWpGaD
Sirolimus—MTOR—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.000174	0.00673	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—NKX2-5—hypothyroidism	0.00017	0.00657	CbGpPWpGaD
Sirolimus—FGF2—IRS-related events triggered by IGF1R—IGF1—hypothyroidism	0.000167	0.00647	CbGpPWpGaD
Sirolimus—FGF2—DAP12 signaling—VAV3—hypothyroidism	0.000167	0.00645	CbGpPWpGaD
Sirolimus—MTOR—Signaling by VEGF—VAV3—hypothyroidism	0.000164	0.00635	CbGpPWpGaD
Sirolimus—FGF2—IGF1R signaling cascade—IGF1—hypothyroidism	0.000163	0.0063	CbGpPWpGaD
Sirolimus—FGF2—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000157	0.00606	CbGpPWpGaD
Sirolimus—FGF2—DAP12 interactions—VAV3—hypothyroidism	0.000157	0.00606	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—TSHB—hypothyroidism	0.000157	0.00605	CbGpPWpGaD
Sirolimus—EIF4E—Gene Expression—THRB—hypothyroidism	0.000154	0.00594	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—CLTC—hypothyroidism	0.000146	0.00566	CbGpPWpGaD
Sirolimus—MTOR—Signaling by ERBB4—PRL—hypothyroidism	0.000142	0.00549	CbGpPWpGaD
Sirolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.00014	0.0054	CbGpPWpGaD
Sirolimus—MTOR—BDNF signaling pathway—VAV3—hypothyroidism	0.000137	0.00531	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—CLTC—hypothyroidism	0.000136	0.00524	CbGpPWpGaD
Sirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—IGF1—hypothyroidism	0.00013	0.00503	CbGpPWpGaD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000128	0.00494	CbGpPWpGaD
Sirolimus—MTOR—EGF/EGFR Signaling Pathway—VAV3—hypothyroidism	0.000125	0.00483	CbGpPWpGaD
Sirolimus—MTOR—IRS-related events triggered by IGF1R—IGF1—hypothyroidism	0.000124	0.0048	CbGpPWpGaD
Sirolimus—FGF2—Adaptive Immune System—CLTC—hypothyroidism	0.000124	0.0048	CbGpPWpGaD
Sirolimus—MTOR—DAP12 signaling—VAV3—hypothyroidism	0.000124	0.00478	CbGpPWpGaD
Sirolimus—MTOR—IGF1R signaling cascade—IGF1—hypothyroidism	0.000121	0.00468	CbGpPWpGaD
Sirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00012	0.00464	CbGpPWpGaD
Sirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000116	0.0045	CbGpPWpGaD
Sirolimus—MTOR—DAP12 interactions—VAV3—hypothyroidism	0.000116	0.0045	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000115	0.00443	CbGpPWpGaD
Sirolimus—CYP3A7—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000113	0.00438	CbGpPWpGaD
Sirolimus—MTOR—Senescence and Autophagy in Cancer—IGF1—hypothyroidism	0.000109	0.00421	CbGpPWpGaD
Sirolimus—FGF2—Signaling by NGF—VAV3—hypothyroidism	0.000107	0.00413	CbGpPWpGaD
Sirolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000101	0.00391	CbGpPWpGaD
Sirolimus—SLC47A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000101	0.00389	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	9.49e-05	0.00367	CbGpPWpGaD
Sirolimus—MTOR—Adaptive Immune System—CLTC—hypothyroidism	9.22e-05	0.00356	CbGpPWpGaD
Sirolimus—FGF2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	9.09e-05	0.00351	CbGpPWpGaD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	9.01e-05	0.00348	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—CLTC—hypothyroidism	8.76e-05	0.00339	CbGpPWpGaD
Sirolimus—CYP3A5—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	8.19e-05	0.00317	CbGpPWpGaD
Sirolimus—MTOR—Signaling by NGF—VAV3—hypothyroidism	7.93e-05	0.00307	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—IYD—hypothyroidism	7.74e-05	0.00299	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TRH—hypothyroidism	7.57e-05	0.00293	CbGpPWpGaD
Sirolimus—FGF2—Immune System—CLTC—hypothyroidism	7.53e-05	0.00291	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—IYD—hypothyroidism	7.1e-05	0.00274	CbGpPWpGaD
Sirolimus—SLCO1B1—SLC-mediated transmembrane transport—AVP—hypothyroidism	7.09e-05	0.00274	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—PRL—hypothyroidism	6.9e-05	0.00267	CbGpPWpGaD
Sirolimus—FGF2—Developmental Biology—VAV3—hypothyroidism	6.9e-05	0.00267	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TSHR—hypothyroidism	6.75e-05	0.00261	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—TSHB—hypothyroidism	6.75e-05	0.00261	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—ATP5O—hypothyroidism	6.58e-05	0.00254	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—CLTC—hypothyroidism	6.43e-05	0.00248	CbGpPWpGaD
Sirolimus—EIF4E—Immune System—VAV3—hypothyroidism	6.39e-05	0.00247	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—TPO—hypothyroidism	6.19e-05	0.00239	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—POMC—hypothyroidism	6.13e-05	0.00237	CbGpPWpGaD
Sirolimus—FGF2—Innate Immune System—VAV3—hypothyroidism	6.1e-05	0.00236	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—ATP5O—hypothyroidism	6.04e-05	0.00233	CbGpPWpGaD
Sirolimus—CYP3A7—Biological oxidations—POMC—hypothyroidism	6.02e-05	0.00233	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—SH2B3—hypothyroidism	6.02e-05	0.00233	CbGpPWpGaD
Sirolimus—EIF4E—Metabolism of proteins—IGF1—hypothyroidism	5.9e-05	0.00228	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	5.73e-05	0.00222	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	5.73e-05	0.00222	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—TPO—hypothyroidism	5.68e-05	0.00219	CbGpPWpGaD
Sirolimus—MTOR—Immune System—CLTC—hypothyroidism	5.59e-05	0.00216	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TRH—hypothyroidism	5.55e-05	0.00215	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—IYD—hypothyroidism	5.13e-05	0.00198	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TSHB—hypothyroidism	4.95e-05	0.00191	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—TSHR—hypothyroidism	4.95e-05	0.00191	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—CLTC—hypothyroidism	4.87e-05	0.00188	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	4.75e-05	0.00184	CbGpPWpGaD
Sirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	4.7e-05	0.00182	CbGpPWpGaD
Sirolimus—FKBP1A—Disease—PRL—hypothyroidism	4.68e-05	0.00181	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	4.58e-05	0.00177	CbGpPWpGaD
Sirolimus—MTOR—Innate Immune System—VAV3—hypothyroidism	4.52e-05	0.00175	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—PRL—hypothyroidism	4.46e-05	0.00173	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—SH2B3—hypothyroidism	4.41e-05	0.00171	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—ATP5O—hypothyroidism	4.36e-05	0.00169	CbGpPWpGaD
Sirolimus—CYP3A5—Biological oxidations—POMC—hypothyroidism	4.35e-05	0.00168	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TRH—hypothyroidism	4.21e-05	0.00163	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—VAV3—hypothyroidism	4.13e-05	0.0016	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—TPO—hypothyroidism	4.1e-05	0.00159	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—AVP—hypothyroidism	3.98e-05	0.00154	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—IYD—hypothyroidism	3.87e-05	0.0015	CbGpPWpGaD
Sirolimus—FGF2—Immune System—PRL—hypothyroidism	3.84e-05	0.00148	CbGpPWpGaD
Sirolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	3.81e-05	0.00147	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TSHB—hypothyroidism	3.75e-05	0.00145	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—TSHR—hypothyroidism	3.75e-05	0.00145	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—CLTC—hypothyroidism	3.61e-05	0.0014	CbGpPWpGaD
Sirolimus—SLCO1B1—Transmembrane transport of small molecules—AVP—hypothyroidism	3.6e-05	0.00139	CbGpPWpGaD
Sirolimus—FGF2—Immune System—VAV3—hypothyroidism	3.55e-05	0.00137	CbGpPWpGaD
Sirolimus—FGF2—Disease—PRL—hypothyroidism	3.54e-05	0.00137	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—SH2B3—hypothyroidism	3.34e-05	0.00129	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—ATP5O—hypothyroidism	3.29e-05	0.00127	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—PRL—hypothyroidism	3.27e-05	0.00127	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TRH—hypothyroidism	3.12e-05	0.00121	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—TPO—hypothyroidism	3.1e-05	0.0012	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—VAV3—hypothyroidism	3.03e-05	0.00117	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—AVP—hypothyroidism	2.92e-05	0.00113	CbGpPWpGaD
Sirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	2.9e-05	0.00112	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—TSHB—hypothyroidism	2.86e-05	0.00111	CbGpPWpGaD
Sirolimus—MTOR—Immune System—PRL—hypothyroidism	2.85e-05	0.0011	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TSHB—hypothyroidism	2.78e-05	0.00108	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—TSHR—hypothyroidism	2.78e-05	0.00108	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—POMC—hypothyroidism	2.64e-05	0.00102	CbGpPWpGaD
Sirolimus—MTOR—Immune System—VAV3—hypothyroidism	2.63e-05	0.00102	CbGpPWpGaD
Sirolimus—MTOR—Disease—PRL—hypothyroidism	2.63e-05	0.00102	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—TSHB—hypothyroidism	2.63e-05	0.00102	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—PIK3C2A—hypothyroidism	2.55e-05	0.000987	CbGpPWpGaD
Sirolimus—EIF4E—Signaling Pathways—IGF1—hypothyroidism	2.54e-05	0.000983	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.52e-05	0.000973	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—SH2B3—hypothyroidism	2.48e-05	0.000959	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—PRL—hypothyroidism	2.48e-05	0.000959	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—IYD—hypothyroidism	2.39e-05	0.000922	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—PIK3C2A—hypothyroidism	2.34e-05	0.000905	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—VAV3—hypothyroidism	2.3e-05	0.000887	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	2.29e-05	0.000886	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—AVP—hypothyroidism	2.21e-05	0.000855	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—SLC5A5—hypothyroidism	2.14e-05	0.000829	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.03e-05	0.000784	CbGpPWpGaD
Sirolimus—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.02e-05	0.000782	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—SLC5A5—hypothyroidism	1.97e-05	0.00076	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—POMC—hypothyroidism	1.94e-05	0.000749	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—TPO—hypothyroidism	1.91e-05	0.000737	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—TSHB—hypothyroidism	1.9e-05	0.000734	CbGpPWpGaD
Sirolimus—FKBP1A—Signaling Pathways—IGF1—hypothyroidism	1.87e-05	0.000721	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—PRL—hypothyroidism	1.84e-05	0.000712	CbGpPWpGaD
Sirolimus—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	1.8e-05	0.000697	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—VAV3—hypothyroidism	1.7e-05	0.000658	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—PIK3C2A—hypothyroidism	1.69e-05	0.000655	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—AVP—hypothyroidism	1.64e-05	0.000634	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—POMC—hypothyroidism	1.47e-05	0.000568	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—TSHB—hypothyroidism	1.43e-05	0.000554	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—SLC5A5—hypothyroidism	1.42e-05	0.00055	CbGpPWpGaD
Sirolimus—FGF2—Signaling Pathways—IGF1—hypothyroidism	1.41e-05	0.000546	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.28e-05	0.000494	CbGpPWpGaD
Sirolimus—SLCO1B1—Metabolism—POMC—hypothyroidism	1.12e-05	0.000434	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—POMC—hypothyroidism	1.09e-05	0.000422	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.07e-05	0.000415	CbGpPWpGaD
Sirolimus—MTOR—Signaling Pathways—IGF1—hypothyroidism	1.05e-05	0.000405	CbGpPWpGaD
Sirolimus—CYP3A7—Metabolism—POMC—hypothyroidism	1.03e-05	0.000398	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—TSHB—hypothyroidism	8.83e-06	0.000341	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	7.87e-06	0.000304	CbGpPWpGaD
Sirolimus—CYP3A5—Metabolism—POMC—hypothyroidism	7.44e-06	0.000288	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—SLC5A5—hypothyroidism	6.61e-06	0.000256	CbGpPWpGaD
Sirolimus—ABCB1—Metabolism—POMC—hypothyroidism	5.61e-06	0.000217	CbGpPWpGaD
Sirolimus—CYP3A4—Metabolism—POMC—hypothyroidism	3.46e-06	0.000134	CbGpPWpGaD
